InsiderClue
Insiders · Profile

Wiley Matthew T.

Chief Commercial Officer at Definium Therapeutics · Chief Commercial Officer at BioXcel Therapeutics. Filing since 4 Apr 2024. CIK 0001759703

DFTX Definium Therapeutics, Inc. Chief Commercial Officer · 2 trades BTAI BioXcel Therapeutics, Inc. Chief Commercial Officer · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DFTX Definium Therapeutics, Inc.
25 Sep 2026
Chief Commercial Officer
Sold on a plan
3,097
$113.26K
0.9%
DFTX Definium Therapeutics, Inc.
25 Jun 2026
Chief Commercial Officer
Sold on a plan
2,867
$129.10K
1.6%
BTAI BioXcel Therapeutics, Inc.
3 Oct 2024
Chief Commercial Officer
Sold on a plan
6,272
$3.45K
24.8%
BTAI BioXcel Therapeutics, Inc.
16 Sep 2024
Chief Commercial Officer
Sold on a plan
215
$148.52
5.1%
BTAI BioXcel Therapeutics, Inc.
17 Jun 2024
Chief Commercial Officer
Sold on a plan
244
$308.10
6.5%
BTAI BioXcel Therapeutics, Inc.
4 Apr 2024
CHIEF COMMERCIAL OFFICER
Sold on a plan
1,008
$2.66K
25.2%
6 decisions on file.